SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000914121-13-000808
Filing Date
2013-12-23
Accepted
2013-12-23 06:01:21
Documents
3
Period of Report
2013-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sa29789428-8k.htm 8-K 38089
2 AMENDED AND RESTATED BYLAWS sa29789428-ex3_1.htm EX-3.1 210061
3 FORM OF INDEMNITY AGREEMENT FOR DIRECTORS AND EXECUTIVE OFFICERS sa29789428-ex10_1.htm EX-10.1 126644
  Complete submission text file 0000914121-13-000808.txt   376054
Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23265 | Film No.: 131293104
SIC: 2834 Pharmaceutical Preparations